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Hearing loss is more prevalent than other disorders 
found at birth. Efforts have been put up towards the early 
identification and treatment of hearing loss by means of 
neonatal hearing screening programs. Aim: prospective 
study with the goal of characterizing the process of 
implementing a Neonatal Auditory Screening Program (NASP) 
at a University Hospital. To analyze hearing loss diagnostic 
investigations in newborns, and to present proposals for 
NASP improvement. Materials and Methods: we studied 
newborns (NB) submitted to Newborn Auditory Screening 
(NAS) by transient evoked otoacoustic emissions (TEOE), 
cochlear-eyelid reflex (CER) and Brainstem Evoked Auditory 
Potential (BEAP). Results: we tested 625 children. In the 
first stage, 458 NBs passed and 155 failed. 122 NBs returned 
to the second stage, and 8 underwent it because they were 
positive for HL risk factors. 12 NBs (1.9%) were referred for 
diagnostic investigation. Of the 5 who returned for the BAEP, 
we observed HL in two NBs. Conclusions: the program 
tested 81.7% of the candidates. The program compliance rate 
was of 68.2%. In the first stage, 26.7% of the NBs failed. The 
program is being implemented and requires constant analyzes 
of its difficulties, aiming at solving them in order to turn the 
Universal Newborn Auditory Screening into reality.
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INTRODUCTION
Today, because of the magnitude of the losses cau-
sed by hearing impairment, this topic has received broad 
attention from health care authorities throughout the world. 
For quite some time now, the need for early detection 
and proper treatment is advocated, since the diagnosis of 
this disorder, usually late, around the third year of life,1-3 
is based only in the child’s demeanor.
The early treatment of hearing loss brings known 
benefits, through the use of hearing aids, all the way to 
a cochlear implant, in order to enhance normal language 
development, especially when done before six months 
of life.3
In Brazil, hearing loss early detection programs 
have been carried out in maternities of 22 states, following 
international recommendations, in a total of 237 services 
registered at the Grupo de Apoio à Triagem Auditiva Ne-
onatal Universal (GATANU - support group to universal 
neonatal hearing screening) and some cities which have 
legislation establishing that it is mandatory to perform 
hearing screening in all newborns.2-4
The present investigation aims at characterizing the 
Neonatal Auditory Screening Program in a University Hos-
pital, analyze the diagnostic investigation of hearing loss 
in newborns and present proposals to enhance neonatal 
hearing screening.
MATERIALS AND METHODS
This study was a cross-sectional contemporary co-
hort. The subjects were all newborns (NB) submitted to 
hearing screening at the hospital from March 01 to August, 
31 of 2005. Three NBs were taken off the study because 
it was not possible to see their charts.
The study project was approved by the Ethics Com-
mittee, on December 13, 2004, under protocol # 324/04. 
Parents or guardians had to sign a free and informed 
consent form.
In order to assess hearing acuity, we used the 
transient otoacoustic emissions hearing accuracy device, 
from Madsen, Accu Screen Pro T model, produced by GN 
Otometrics, near the hospital discharge hour of the NBs 
admitted to joint quarters or after clinical stabilization. 
The behavioral assessment was carried out by means of 
studying the cochleopalpebral reflex (CPR), using an agogo 
as an instrument, at the time of the emissions test.
In this first step, the in-hospital tests were carried 
out from Monday through Friday. The untested NBs and 
those discharged on the weekends and/or holidays were 
referred to outpatient evaluation between two and four 
weeks of life. The tests were conducted by speech and 
hearing therapists. The probe for otoacoustic emissions 
capture was coupled to the newborns’ outer ears, prefe-
rably during their natural sleep and after breastfeeding. 
Should the test yield a hearing alteration, it was repeated 
on the second stage of the program, between 7 and 15 
days after hospital discharge.
On the second stage, the middle ear was assessed by 
means of the tympanometric curve in those patients with 
altered screening tests. These patients would be referred 
to medical assessment for new tests.
When indicated, the NB would go through a third 
investigation stage, being then assessed by Brainstem 
Evoked Auditory Potential (BEAP), by an interacoustics 
ABR EP15 system.
Statistical Analysis
The data collected was organized and analyzed 
by the Epidata 3.0® and Epi-Info 6.0® software. For the 
numerical variables, we calculated the absolute values and 
the variability and position descriptive measures (mean 
and mean standard deviation). In order to check the sig-
nificance, we used the X2 (α < 5%) test.
RESULTS
During the study period, we had 774 live births in 
the maternity. We included in the study two newborns 
from home deliveries who were admitted after birth. One 
NB was transferred to another hospital. Four NBs died in 
the obstetric center and six died in the neonatal unit. Thus, 
a total of 765 NBs were eligible for neonatal auditory scre-
ening. On figure 1, we see the program stages’ flowchart 
and the newborns evaluated during the period.
Of all the 625 patients tested, 595 (95.2%) underwent 
auditory testing by TOAE during their hospital stay. 30 NBs 
who returned to the outpatient ward were tested (4.8%). 
Of the 765 NBs eligible to the auditory test, 140 (18.3%) 
were not tested during the hospital stay and did not return 
to the outpatient test.
In the first Newborn Auditory Screening - NAS, 
the TOAE tests were normal - negative/passed - in 458 
NBs (73.3%) and altered - positive/failed - in 167 (26.7%). 
The Cochleopalpebral reflex - CPR was altered in 38 NBs 
(6.1%) (Table 1).
The unilateral failure type was identified in 97 NBs 
(62.2%), while bilateral failure happened in 58 (37.4%) 
from the total of 155 emission tests that failed.
For the second NAS stage, 122 NBs participated and 
8 of them who passed the first stage tests returned for ha-
ving risk factors. In the retest, 114 NBs passed the TOAEs 
and 8 failed, and of these 5 (62.5%) failed bilaterally. The 
CPR was absent in 8 NBs (Table 2).
Tympanometry was normal in 12 patients who 
failed the retest. These 12 patients were referred to the 
otorhinolaryngology department and for BAEP evaluation. 
The NBs born in the first 6 months of implantation, when 
we still did not have the test and who were waiting for 
it, were called in. Six NBs were located by their phone 
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numbers recorded in their charts. One of the NBs is being 
followed up in another municipality. Five children came 
for investigation and BAEP. In these we confirmed the 
hearing loss in two, representing 0.32% from the total 
population studied (Chart 1).
Table 1. Distribution of the TOAE and CPR test results in the first 
stage.
CPR 
EOAT
Passed Failed Total
n % n % n %
Passed 458 73.3 12 1.9 470 75.2
Failed 129 20.6 26 4.2 155 24.8
Total 587 93.9 38 6.1 625 100
Table 2. Distribution of the TOAE and CPR test results in the second 
stage.
CPR
TOAE
Passed Failed Total
n % n % n %
Passed a110 90.1 b4 3.3 114 93.4
Failed 4 3.3 4 3.3 8 6.6
Total 114 93.4 8 6.6 122 100
a7 of the 110 belonged to the risk factor follow up
b1 of the 4 belonged to the risk factor follow up.
Figure 1. Flowchart of the program stages and the number of NBs 
assessed in the period.
Chart 1. Follow up of NBs who failed the 1st and 2nd stages with 
indication of BAEP. 
NB GA LMD/CSa Indicador de risco PEATE
Risk indi-
cator
BAEP não realizado
1 35.7 / - Down syndrome Not performed
2 42.4 / - HIV+ mother Not performed
3 - / 33.9 Illicit drugs Not performed
4 37.3 / -
Progeroid syndrome. 
craniofacial anomaly
Normal on the R and 
fail on the L
5 40.5 / - Absent Normal
6 - / 40.7 Family history Not performed
7 38.0 / - Family history Normal
8 38.0 / - Smoking Not performed
9 34.1 / -
ICU. ototoxic. Skull 
anomaly. asphyxia 
Bilateral retrocochle-
ar  alteration
10 37.4 / -
Down syndrome. 
Skull anomaly
Normal
11 - / 40.4
Syphilis. Craniofacial 
anomaly
Follow up in another 
district
12 28.6 / 28.4b
Very low weight. ICU. 
ototoxic
Not performed
aGA LMD/CS = Gestational age by the last menstruation date or by 
Capurro sommatic.
gestational age by Ballard.
The main diagnosis found among the 57 NBs ad-
mitted to the ICU are represented on Table 3. From these, 
7 NBs failed the TOAEs in the first stage. This result bears 
statistical significance when compared to the NBs who 
did not stay in the ICU.
The risk indicators for congenital hearing loss seen 
in the study were analyzed separately, according to Tables 
4 and 5.
The association of risk factors together showed a 
trend towards statistical significance to present a TOAE 
failure (Table 5).
There was no association between the use of oto-
toxic medication and the rate of TOAE failures (p>0.05) 
(Tables 4 and 6).
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Table 3. NBs distribution in the ICU regardless of stay duration in 
relation to the TOAE results in the first stage.
TOAE
ICU
Passed Failed Total
N % N % n %
Yes 50 8.0 7 1.1 57 9.1
No 420 67.2 148 23.7 568 90.9
Total 470 75.2 155 24.8 625 100.0
X2 = 5.27 p = 0.02168
Table 4. Distribution of the high risk factors for hearing loss among 
the NBs studied in relation to the results obtained from the TOAE 
test.
HIGH RISK FACTOR N (%)
TOAE
Passed Failed
Intraventricular hemorrhage 9 (1.4) 8 1
Mother HIV positive 5 (0.8) 3 2
 ICU ≥ 2 days 47 (7.5) 41 6
Weight < 1.500g 18 (2.9) 14 4
Apgar 1º (1-3) 15 (2.4) 13 2
Apgar 5º (1-5) 5 (0.8) 5 0
Syndromes 6 (1.0) 2 4
Family history 38 (6.1) 29 9
Craniofacial anomalies 6 (1.0) 2 4
Toxoplasmosis 4 (0.6) 4 0
Syphilis 4 (0.6) 3 1
Cytomegalovirus 2 (0.3) 1 1
Mechanical ventilation 3 (0.5) 2 1
Drugs (tobacco. alcohol. illegal) 47 (7.5) 35 12
Ototoxic medication in gestation 46 (7.4) 36 10
Ototoxic medication in the NB 43 (6.8) 34 9
Table 5. Results from the TOAE tests in relation to the number of risk 
factors observed.
Number of Risk Factors Number of NBs
TOAE
Passed Failed
0 438 320 118
1 118 97 21
2 29 22 7
3 12 10 2
4 16 13 3
5 3 2 1
6 6 5 1
7 1 1 0
8 1 0 1
9 1 0 1
Total 625 470 155
X2= 3,6 p = 0,0578
Table 6. Distribution of the main ototoxic drugs used in the NBs 
admitted to the neonatal ICU.
Ototoxic medication n %
Aminoglycosides 38 6,1
Ampicillin 37 5,9
Vancomycin 4 0,6
Furosemide 3 0,5
Others 14 2,2
Total 96 15.4
DISCUSSION
According to the references and the quality indi-
cators defined by the JCIH in  2000, in order for a NAS 
program to be universal, within six months of imple-
mentation it must reach a minimum of 95% of infants 
assessed during post-partum admission, or before one 
month of life.3,5 The NAS implementation study in this 
university hospital tracked 81.7% of the 765 NBs eligible 
for the test. This rate of scope, although it is not ideal, is 
very similar to the reality found in other services at this 
same implementation stage. Kennedy et al., in 2005, in a 
cohort study assessed 25,609 NBs in the United Kingdom 
in three years, showed that only 83% of these NBs were 
screened.6 Chapchap and Segre, in the year 2000, assessed 
4.196 NBs, recording 90.6% of the NBs tested.7 Therefore, 
the 95% reference was not reached in the first six months 
of implementation.
The screening was carried out in 595 NBs (95.2%) 
during the stay in joint quarters at the Neonatal Unit. 
17.96% of the NBs returned for outpatient testing, 30 of the 
167 NBs expected. The rate of “no shows” at the outpatient 
ward screening first stage was of 82%. A study carried out 
in Malaysia, by Mukari et al.8, involving 4,437 newborns in 
the period of April, 2003 through February, 2004, shows 
an unsatisfactory scope rate in the first test (84.64%), low 
rate of outpatient return (11.97%) and return for a new 
test for those who failed (56.97%). Of the 16 NBs with 
hearing loss identified in the study, only one had suffered 
an intervention. In order to identify the factors which led 
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to the unsatisfactory results in the program, the authors 
interviewed 314 mothers who did not return with their 
children after we found them through an active search. 
The main reason reported was a communication failure.
For the narrow scope in the first maternity test, 
Mukari et al. relate to hospital discharge before 24 hours 
after birth to the possibility of return after discharge, and 
the test performance was no longer a priority during hos-
pital stay; and the fact that the examiners worked from 
Monday to Friday, and the test was not performed in those 
children to be discharged during the weekend. 
On the NAS first stage, in this service, 458 NBs 
(73.3%) passed the TOAE and CPR tests and 167 (26.7%) 
failed, as per described on Table 1. Results point to a TOAE 
rate of failure of 24.8% (155 RNs) (Table 1). Pádua et al., 
2005, observed a test positiveness 9.5% on the 1,127 NBs 
examined in a 9 month NAS study.9
As we analyzed the failures reported by Wro-
blewska-Seniuk et al. in 2005, we observed a positive 
test in 16.28% of the total of 5,601 NBs studied. Of these, 
61.5% failed unilaterally on the TOAE test.10 The unilateral 
failures observed by Pádua et al. were of 67.3%9, and such 
values are similar to the ones observed in the present 
study, representing 62.6% of the positive TOAEs. In 2003, 
Segre mentions that the rate of UNAS retesting can reach 
up to 10%.11
It is a fact that the high rate of TOAE false-positives 
represent a disadvantage of this type of test. This NAS had 
16.9% of false-positive emissions on the first stage of the 
assessment. Marone et al., 2005, reported 15.5% of false 
positive tests.12
The short hospital stay period after birth can raise 
the false-positive rate. The presence of amniotic liquid and 
caseous vernix in the auditory canal may impair sound 
transmission and cause failure in the emissions test.10 It is 
suggested that a serial repetition of the altered tests, still 
during hospital stay can reduce such problem. The test 
repetition would require a longer hospital stay for the 
NB.10,13,14 In the hospital of our study, children are dis-
charged between 36 and 48 hours of life. Korres et al., in 
a recent publication from 2006, observed a failure rate in 
emissions in only 3.1% of the NBs in the first three years 
of the program. However, the children were kept in the 
hospital in the first 4 to 5 days of life.13
All the children with the first TOAE positive test 
and or without CPR, were referred for retesting in the lab. 
And, following the guidelines suggested by the JCIH, the 
NBs with some high risk indication concerning hearing 
loss, because of the risk of progressive loss or a loss of 
late onset, were referred for follow up every six months 
for three years.3,12 Of this group, 8 children returned for 
outpatient follow up.
For the second stage with 122 children, 114 were 
among the 167 NBs who failed the first stage, representing 
68.2% of program compliance, that is, the children who 
failed the first stage and returned for retesting. This value 
is similar to the 73.1% described in the Durante et al study 
and more expressive than the 41.8% compliance observed 
by Korres et al. at the end of the fifth year of universal 
screening with TOAE only (Chart 2).2,13 Thus, a follow 
up above the 70% reference indicated by the JCIH in the 
beginning of the NAS implementation was near reach.3
On the second screening stage, 6.6% of the children 
failed the TOAE test. In the studies reported above, the 
authors observed higher failure rates in the retest with 
TOAE, from 23.81 to 39.91%.10,2,13
The behavioral assessment is considered an impor-
tant part of the investigation as it provides information 
of how auditory resources are used by the child and for 
assessing central auditory pathways. The presence of 
behavioral information suggests integrity of the hearing 
pathways and no severe hearing loss.12
In the present investigation, CPR was absent in 6.1% 
of the time in the first screening stage and in 6.5% on 
the second. In the study carried out by Pádua et al. they 
found an index of 1.8% of CPR alterations at the UNAS.9 
Analyzing only the CPR results on the second stage of the 
program under investigation, we noticed that four children 
in the study failed only the reflex behavioral evaluation, 
representing 0.6% of the study subjects.
12 children were referred for diagnostic investiga-
tion follow up, representing 1.9% of the NBs tested in the 
Neonatal Auditory Screening Program in six months and 
1.6% of the live births eligible for hearing screening (765). 
The NAS quality indicator proposed by the JCIH indicates 
that at the end of the first year of the program, less than 
4% of the NBs screened should be referred as a goal to 
avoid high false-positive rates.3
On the 12 children referred for the third stage of the 
follow up, we see the presence of at least one risk factor 
in 11 of them (Chart 1).
187 newborns with risk factors for hearing loss were 
identified, representing 29.92% of the sample. Of these, 37 
newborns failed TOAEs (Table 5). The rate of emissions 
with failure, when associated with risk factors showed a 
tendency to having statistical significance. Some author 
report the presence of risk factors in 6.910, 12.52and 
14.7%9of the NBs eligible to universal screening. 
Nóbrega et al. described congenital rubella as one 
of the main etiologies in children, even showing a high 
percentage of loss for unknown cause.15 Congenital 
infections are described as being responsible for a large 
number of hearing losses in Brazil. Among them, we have 
infection by cytomegalovirus, the most common infection 
of the TORCH complex.14 Marone et al. found perinatal 
infections in 25.8% of the NBs investigated.12
Maternal infection by HIV can also be considered a 
risk factor because of vertical transmission.12 In our study, 
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we found maternal infection in 0.8% of the cases. Chandra-
sekhar et al., in the year 2000 and Rezende et al., in 2004, 
point to possible direct effects of the virus in the inner 
ear, yet to be clarified among the causes of hearing loss in 
HIV-positive patients because of its neurotropic behavior 
and involvement of the cochleovestibular nerve. Another 
mechanism would be ototoxicity caused by antiretroviral 
drugs, zidovudine among them, used in the prophylactic 
treatment of NB from HIV-infected mothers.16-19
One important factor observed in the sample is 
the presence of hearing loss in relatives of the first to 
the third grades (6.1%). Hereditary can represent up to 
50% of hearing loss in childhood.20 Nóbrega et al. relate 
to genetic causes around 14% of the causes for hearing 
deficit in children and teenagers.15 It is believed that the 
high prevalence of mutations in the GJB2 gene justifies the 
inclusion of genetic screening to complement the current 
investigation approaches.1
It is estimated that the prevalence of hearing deficit 
in children with past history of ICU stay increase in 6 fold, 
because of the higher risks of comorbidities and compli-
cations.15 The myelinization of the auditory nerve fibers 
start on the 24th week of gestation, on the 26th week the 
Organ of Corti is already morphologically similar to that 
of the adult and the cochlear auditory evoked potentials 
are present as of the 24th week.12 For these reasons, we 
took into account the use of ototoxic medications during 
gestation, assuming a possible ototoxic effect for the fetus. 
The number of pregnant women with a medical chart who 
used ototoxic medication was of 46 (7.4%), and 21.7% 
failed the emissions (Table 4). There was no relationship 
between the use of ototoxic medication during gestation 
and the increase in the number of TOAE failure in the 
first stage (p>0.05).
Of the 12 children referred for a third stage investi-
gation, five underwent brainstem audiometry test. Results 
were altered in two children, representing 0.32% of the 
study population (Chart 2). Hall et al., 2004, studying the 
combination of TOAE with BAEP, describing a 2% rate of 
positive screening.21-23
The goal established by the JCIH is reaching diagno-
sis before 3 months and perform intervention by 6 months 
of age. In the study program, hearing loss diagnosis of the 
two children was carried out between 7 and 10 months 
of age. They are being evaluated by the multidisciplinary 
auditory development follow up program for proper tre-
atment. The children without BAEP test are being looked 
for, for testing.
After the screening results in 81.7% of the NBs 
eligible, we tried to identify the factors that could justify 
them. Checking all the births at the maternity from the 
Obstetric Center Records and crossing such data with 
those from NBs who had been submitted to screening, we 
noticed that of the births which happened on Thursdays 
and Fridays of NBs who did not undergo TOAEs before 
hospital discharge, 57.6% were born in these two days of 
the week. Of these, 20.7% came from other towns.
Korres et al. (2006) suggest the factors that can make 
an auditory screening program a success. During the first 
three years of the program implementation in Athens, the 
authors identified the probable causes of narrow scope. 
In the two following years, they continued to enhance the 
program, and currently, the program reached the metrics 
proposed by the JCIH. The first testing before discharge 
went from 58.9 to 96.3% and the return for tests in the 
outpatient ward increased from 27.8 to 41.8%. The authors 
relate the good results especially to the fact that NBs are 
being discharged between four and five days of life. The 
first test is carried out before 24 hours, and when it fails, 
it is repeated many times until the day of discharge. The 
program also includes tests during the 7 days of the week, 
training of all the professionals involved with the care of 
pregnant women, from prenatal care to the delivery, to the 
care given to the newborn all the way to their discharge 
and follow up. NBs who failed had their testing repeated 
many times until the time they went home is stressed by 
the authors as the main factor responsible for the program 
to have reached only 2.1% of fails in the first OAE. The-
se NBs who could effectively have hearing loss and the 
need to follow the program were more easily followed 
in the continuation of the investigation and intervention. 
Another thing that was stressed was to alert the parents 
regarding the probable risk of hearing deficit in their chil-
dren, since the test was carried out many times, engaging 
them even more emphatically regarding follow up after 
going home.13,14
Korres et al.13,14 and Mukari et al.8 reported good 
results after implementing some proposals to improve 
hearing screening programs.
During the study, the NAS in this university hospital 
completed one year in the beginning of the implemen-
tation. Some improvements started after focusing more 
intensively on the attempt to guarantee the performance of 
these tests before maternity discharge. Other improvements 
are still to be implemented in order to increase the rates 
of compliance and reduce the rates of false-positive.
The joint quarters team and the Neonatal Unit is 
more prepared to identify the NBs who have not yet been 
tested. The members of the medical team are alert as they 
discharge these children. As far as weekends and holidays 
are concerned, there is the need to create mechanisms for 
NBs with discharge scheduled for these days, either be 
tested before, or that the tests be performed even during 
these days by appointed professionals.
At the time of hospital discharge, we suggest to 
identify the charts of NBs who suffered the test and it was 
normal and the ones who failed, and who should return. 
The ones who were not registered, therefore were not 
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submitted to the first TOAE, and are being discharged, 
may be identified later on, for active search in case they 
miss their return scheduled to the outpatient ward.
In order to better educate parents at the time of 
discharge, we suggest the creation of an educational card. 
In such a card, there must be the identification, data and 
time of hospital discharge; date, time and place of return; 
and also the telephone number of the program for the 
possibility of a new scheduling of the return visit when 
necessary.
The disclosure to the community by means of com-
munication, the alert about the need to undergo hearing 
deficit screening as early as possible and the involvement 
of all health care professionals from a primary level, du-
ring prenatal care and during pediatric care, are strategies 
to educate parents regarding the importance of hearing 
screening. Parents may become inspectors of the program’s 
effectiveness, as it happens today with the foot test.
Because of its repercussion on citizenship, hearing 
loss represents a public health problem. Health care au-
thorities have the responsibility of stimulating the imple-
mentation of programs in the many cities, creating points 
of reference for easier access by the population. And after 
implementing them, means must be created to assure their 
real effectiveness.
The data from this study are related to the first six 
months of the program. There is the need to update the 
data in the program’s sequence and check for the effective 
improvement on test rates in its many stages. The imple-
mentation of a neonatal hearing screening in a university 
hospital, which serves only the public health care system, 
bears innumerous difficulties. The involvement of all the 
members of the multidisciplinary team is paramount.
CONCLUSIONS
The first 6 months of implementation of the Neona-
tal Hearing Screening Program in the University Hospital 
have an engaging rate of 81.7% of the eligible newborns. 
The compliance rate, in other words, return of newborns 
with TOAE failure was of 68.2%. Of the NBs tested, 1.9% 
required investigation by the BAEP and 0.32% had hea-
ring loss.
Some important things were noticed at the time 
of implementation: team dedication and commitment, 
disclosure and family education, and their interest in such 
a program.
In order to improve the NAS program scope we pro-
pose: that the tests be repeated before hospital discharge, 
tests be carried out during the weekends and holidays, a 
greater integration of the health care team, distribute ex-
planatory cards to the parents during hospital stay, better 
information on the press and greater governmental action 
in order to divulge NAS.
The program is still in its implementation phase; 
the difficulties found and others that will come must be 
constantly analyzed and the solutions put into practice in 
order to make the screening program truly universal.
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